JPWO2023170547A5 - - Google Patents
Info
- Publication number
- JPWO2023170547A5 JPWO2023170547A5 JP2024553437A JP2024553437A JPWO2023170547A5 JP WO2023170547 A5 JPWO2023170547 A5 JP WO2023170547A5 JP 2024553437 A JP2024553437 A JP 2024553437A JP 2024553437 A JP2024553437 A JP 2024553437A JP WO2023170547 A5 JPWO2023170547 A5 JP WO2023170547A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- aticaplant
- crystalline form
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263317483P | 2022-03-07 | 2022-03-07 | |
| US63/317,483 | 2022-03-07 | ||
| PCT/IB2023/052082 WO2023170547A1 (en) | 2022-03-07 | 2023-03-06 | Pure forms of crystalline aticaprant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508071A JP2025508071A (ja) | 2025-03-21 |
| JPWO2023170547A5 true JPWO2023170547A5 (https=) | 2026-02-17 |
| JP2025508071A5 JP2025508071A5 (https=) | 2026-02-17 |
Family
ID=85979414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553437A Pending JP2025508071A (ja) | 2022-03-07 | 2023-03-06 | 純粋な形態の結晶質アチカプラント |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20230348377A1 (https=) |
| EP (1) | EP4489748A1 (https=) |
| JP (1) | JP2025508071A (https=) |
| KR (1) | KR20240158951A (https=) |
| CN (1) | CN119156210A (https=) |
| AU (1) | AU2023231493A1 (https=) |
| CA (1) | CA3254503A1 (https=) |
| CL (1) | CL2024002643A1 (https=) |
| CO (1) | CO2024012457A2 (https=) |
| IL (1) | IL315411A (https=) |
| JO (1) | JOP20240195A1 (https=) |
| MX (1) | MX2024010978A (https=) |
| PE (1) | PE20242109A1 (https=) |
| TW (1) | TW202345795A (https=) |
| WO (1) | WO2023170547A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12161622B2 (en) | 2021-05-04 | 2024-12-10 | Janssen Pharmaceuticals, Inc. | Compositions and methods for the treatment of depression |
| WO2023170554A1 (en) | 2022-03-07 | 2023-09-14 | Janssen Pharmaceuticals, Inc. | Compositions comprising aticaprant |
| WO2023170550A1 (en) | 2022-03-07 | 2023-09-14 | Janssen Pharmaceuticals, Inc. | Polymorph forms of aticaprant for use in treating major depressive disorder |
| CN117903050B (zh) * | 2024-03-15 | 2024-05-17 | 中国药科大学 | 阿立哌唑共晶及其药物组合物和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5345637B2 (ja) * | 2008-01-22 | 2013-11-20 | イーライ リリー アンド カンパニー | κ選択的オピオイド受容体アンタゴニスト |
| US10316021B2 (en) * | 2016-11-28 | 2019-06-11 | Pfizer Inc. | Heteroarylphenoxy benzamide kappa opioid ligands |
| PH12023552963A1 (en) * | 2021-05-04 | 2024-03-11 | Janssen Pharmaceuticals Inc | Compositions and methods for the treatment of depression |
-
2023
- 2023-03-06 AU AU2023231493A patent/AU2023231493A1/en active Pending
- 2023-03-06 CA CA3254503A patent/CA3254503A1/en active Pending
- 2023-03-06 TW TW112108147A patent/TW202345795A/zh unknown
- 2023-03-06 EP EP23715931.4A patent/EP4489748A1/en active Pending
- 2023-03-06 JP JP2024553437A patent/JP2025508071A/ja active Pending
- 2023-03-06 KR KR1020247033036A patent/KR20240158951A/ko active Pending
- 2023-03-06 US US18/179,025 patent/US20230348377A1/en not_active Abandoned
- 2023-03-06 IL IL315411A patent/IL315411A/en unknown
- 2023-03-06 WO PCT/IB2023/052082 patent/WO2023170547A1/en not_active Ceased
- 2023-03-06 CN CN202380038807.1A patent/CN119156210A/zh active Pending
- 2023-03-06 PE PE2024001920A patent/PE20242109A1/es unknown
-
2024
- 2024-09-03 CL CL2024002643A patent/CL2024002643A1/es unknown
- 2024-09-05 JO JOJO/P/2024/0195A patent/JOP20240195A1/ar unknown
- 2024-09-06 MX MX2024010978A patent/MX2024010978A/es unknown
- 2024-09-13 CO CONC2024/0012457A patent/CO2024012457A2/es unknown
-
2025
- 2025-06-30 US US19/254,965 patent/US20250326714A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022084717A5 (https=) | ||
| AU781141B2 (en) | Novel use of phenylheteroalkylamine derivatives | |
| JP2019059760A5 (https=) | ||
| JP2001513557A (ja) | 痛みを処置するための方法 | |
| JP2022191257A5 (https=) | ||
| DE69722258T2 (de) | Neue verbindungen nutlich als neuroschützende mittel | |
| JPWO2020245133A5 (https=) | ||
| JP2011518833A (ja) | 治療剤としての置換ガンマラクタム | |
| JP2004502670A5 (https=) | ||
| AU2006242950A1 (en) | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3 -receptor ligands | |
| JPH04507421A (ja) | ５―（１―アミノシクロヘキシル）―２（１ｈ）―ピリジノン及び関連化合物 | |
| JP2020073513A (ja) | α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法 | |
| JPWO2023170547A5 (https=) | ||
| US6455567B1 (en) | Method of treatment | |
| JPWO2021134086A5 (https=) | ||
| RU2009111337A (ru) | N-(2-гидроксиэтил)-n-метил-4-(хинолин-8-ил(1-тиазол-4-илметил)пиперидин-4-илиден)метил)бензамид, способ его получения и его применение для лечения боли, тревоги и депрессии | |
| JP2007077148A (ja) | うつ病患者における睡眠障害の処置を目的とした医薬品を得るためのアゴメラチンの使用 | |
| IL315409A (en) | Polymorph forms of aticaprant for use in treating major depressive disorder | |
| JPWO2020178767A5 (https=) | ||
| JPWO2023170550A5 (https=) | ||
| JP2006523674A (ja) | 慢性閉塞性肺疾患（ｃｏｐｄ）のための組合せ治療法 | |
| JPWO2020169736A5 (https=) | ||
| JPWO2021087432A5 (https=) | ||
| JPWO2020234782A5 (https=) | ||
| KR20090035448A (ko) | 뇌신경 보호를 위한 병용요법 |